- Home
- NYC vs ALUR Comparison
NYC vs ALUR Comparison
Compare NYC & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYC
- ALUR
- Stock Information
- Founded
- NYC 2013
- ALUR 2009
- Country
- NYC United States
- ALUR United States
- Employees
- NYC N/A
- ALUR 137
- Industry
- NYC Real Estate
- ALUR
- Sector
- NYC Finance
- ALUR
- Exchange
- NYC Nasdaq
- ALUR Nasdaq
- Market Cap
- NYC 24.9M
- ALUR 17.3M
- IPO Year
- NYC N/A
- ALUR N/A
- Fundamental
- Price
- NYC $12.62
- ALUR $2.52
- Analyst Decision
- NYC
- ALUR Strong Buy
- Analyst Count
- NYC 0
- ALUR 3
- Target Price
- NYC N/A
- ALUR $22.83
- AVG Volume (30 Days)
- NYC 6.2K
- ALUR 89.4K
- Earning Date
- NYC 08-08-2025
- ALUR 08-12-2025
- Dividend Yield
- NYC N/A
- ALUR N/A
- EPS Growth
- NYC N/A
- ALUR N/A
- EPS
- NYC N/A
- ALUR N/A
- Revenue
- NYC $58,397,000.00
- ALUR $28,304,000.00
- Revenue This Year
- NYC $8.40
- ALUR N/A
- Revenue Next Year
- NYC $1.62
- ALUR $49.37
- P/E Ratio
- NYC N/A
- ALUR N/A
- Revenue Growth
- NYC N/A
- ALUR N/A
- 52 Week Low
- NYC $7.55
- ALUR $2.15
- 52 Week High
- NYC $13.60
- ALUR $39.91
- Technical
- Relative Strength Index (RSI)
- NYC 62.16
- ALUR 46.27
- Support Level
- NYC $8.85
- ALUR $2.38
- Resistance Level
- NYC $10.50
- ALUR $2.66
- Average True Range (ATR)
- NYC 0.85
- ALUR 0.14
- MACD
- NYC 0.35
- ALUR -0.01
- Stochastic Oscillator
- NYC 79.66
- ALUR 41.67
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.